drugset / Trial / NCT00621192

Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections

NCT00621192

Phase 1/2 Completed 200 enrolled The Emmes Company, LLC
NaSingle-groupOpen-labelTreatment

Summary

Meropenem is an antibiotic that is commonly used to treat serious infections. Although it is used in premature and young infants, the correct dose is not known. The purpose of this study is to determine the correct dose and the safety of meropenem for the treatment of complicated intra-abdominal infections in these young babies.

Timeline

Start
2008-06
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Meropenem Small molecule 20 mg/kg Intravenous
Subject Meropenem Small molecule 30 mg/kg Intravenous